The National Pharmaceutical Council (NPC) has commented on the recently updated and released value assessment framework from the Institute of Clinical and Economic Review (ICER). Among other improvements noted by NPC, it appears that, although ICER has not eliminated its budget threshold, it will no longer calculate a value-based benchmark price based on a budget threshold.
In addition to the guiding practices, NPC has produced several educational resources about value assessment frameworks:
- Video: Incorporating Stakeholder Views Into Value Assessment Frameworks
- Current Landscape: Value Assessment Frameworks
- Assessing Value: Promise and Pitfalls Conference and Video
Find out more here. (Source: NPC, 2/1/17)